Keyphrases
CD8+ T Lymphocytes
100%
Cytotoxic T Cells
100%
Cell Isolation
80%
Cell-based
50%
Highly Effective
50%
Cytotoxicity Assay
40%
Adoptive Cell Therapy
40%
Isolation Method
40%
Non-adherent
40%
Molecular Characteristics
20%
Release Devices
20%
Fluorescence Characteristics
20%
Expressed Protein
20%
Viable Cells
20%
Killing Efficiency
20%
Killer T Cells
20%
Feasibility Trial
20%
CD8+ Cytotoxic T Lymphocytes
20%
Clinical Tool
20%
High Efficiency
20%
Selection Criteria
20%
Cell Identification
20%
Array Size
20%
Cell Array
20%
Tumor
20%
High-throughput Technologies
20%
Fluorescence Signatures
20%
Image Cytometry
20%
Time-resolved
20%
High-throughput Image
20%
Market Application
20%
Solid Tumors
10%
University of North Carolina
10%
Microsystems
10%
Epitope
10%
Commercially Available
10%
Lymphocytes
10%
Tumor Cells
10%
Grant Applications
10%
Microarray
10%
Natural Killer Cells
10%
Biotechnology Firms
10%
Leukemia
10%
Ex Vivo Expansion
10%
Antigen-specific
10%
Chapel Hill
10%
Tumor Antigen
10%
Highly Active
10%
Molecular Characterization
10%
T Cell Receptor
10%
Medicine and Dentistry
CD8+ T Lymphocyte
100%
Cytotoxic T-Cell
100%
Cell Therapy
41%
Cytotoxicity Assay
33%
Image Cytometry
16%
T Lymphocyte Receptor
16%
Killer Cell
16%
Cells of the Immune System
16%
Antigen Specificity
16%
Neoplasm
16%
Solid Malignant Neoplasm
8%
Morphology
8%
Tumor Antigen
8%
Epitope
8%
Lymphocyte
8%
Leukemia
8%
T Cell
8%
Immunotherapy
8%
Health Care Cost
8%
Ex Vivo
8%
Tumor Cell
8%
Immunology and Microbiology
CD8+ T Lymphocyte
100%
Cytotoxic T Cell
100%
Cell Isolation
50%
Isolation Procedure
33%
Morphology
16%
Cells of the Immune System
16%
Killer Cell
16%
Cytotoxicity
16%
Surface Property
8%
Tumor Antigen
8%
Antigen Specificity
8%
Lymphocyte
8%
T Cell Receptor
8%
Immunotherapy
8%
T Cell
8%
Tumor Cell
8%
Epitope
8%
Scale up
8%